CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells.
Open Access
- 15 July 1992
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 118 (2) , 457-466
- https://doi.org/10.1083/jcb.118.2.457
Abstract
Neutrophil adherence to cytokine-activated endothelial cell (EC) monolayers depends on the expression of the endothelial leukocyte adhesion molecule-1 (ELAM-1). The ligand for ELAM-1 is the sialylated Lewis-x antigen (SLe(x)) structure. The selectin LAM-1 (or LECAM-1) has been described as one of the SLe(x)-presenting glycoproteins involved in neutrophil binding to ELAM-1. Other presenter molecules have not yet been described. Our data demonstrate that the carcinoembryonic antigen (CEA)-like surface molecules on neutrophils--known as the nonspecific cross-reacting antigens (NCAs)--are involved in neutrophil adherence to monolayers of IL-1-beta-activated EC. The NCAs are recognized by CD66 (NCA-160 and NCA-90) and CD67 (NCA-95). Because NCA-95 and NCA-90 have previously been found to be phosphatidylinositol (PI)-linked, paroxysmal nocturnal hemoglobinuria (PNH) neutrophils (which lack PI-linked surface proteins) were tested as well. PNH neutrophils showed a diminished binding to activated EC. CD66 (on PNH cells still recognizing the transmembrane NCA-160 form) still inhibited the adherence of PNH cells to IL-1-beta-activated EC, but to a limited extent. Soluble CEA(-related) antigens inhibited normal neutrophil adherence as well, whereas neutrophil transmigration was unaffected. Sialidase-treatment as well as CD66 preclearing abolished the inhibitory capacity of the CEA(-related) antigens. The binding of soluble CEA antigens to IL-1-beta-pretreated EC was blocked by anti-ELAM-1. These soluble antigens, as well as the neutrophil NCA-160 and NCA-90, both recognized by CD66 antibodies, presented the SLe(x) determinant. Together, these findings indicate that the CD66 antigens (i.e., NCA-160/NCA-90) function as presenter molecules of the SLe(x) oligosaccharide structures on neutrophils that bind to ELAM-1 on EC.Keywords
This publication has 68 references indexed in Scilit:
- Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: Homophilic and heterophilic adhesionPublished by Elsevier ,2004
- Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys.Journal of Clinical Investigation, 1991
- Recognition by Elam-1 of the Sialyl-Le x Determinant on Myeloid and Tumor CellsScience, 1990
- A blocking monoclonal antibody to endothelial-leukocyte adhesion molecule-1 (ELAM1)Biochemical and Biophysical Research Communications, 1990
- Expression of an NCA cDNA in NIH3T3 cells yields a 110K glycoprotein, which is anchored into the membrane via glycosyl-phosphatidylinositolBiochemical and Biophysical Research Communications, 1989
- Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion moleculePublished by Elsevier ,1989
- Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration.Journal of Clinical Investigation, 1988
- Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells.Journal of Clinical Investigation, 1988
- Molecular cloning of a gene for a member of carcinoembryonic antigen (CEA) gene family; Signal peptide and N-terminal domain sequences of nonspecific crossreacting antigen (NCA)Biochemical and Biophysical Research Communications, 1987
- Myeloid‐associated antigen 3‐α‐fucosyl‐N‐acetyllactosamine (FAL): location on various granulocyte membrane glycoproteins and masking upon monocytic differentiationEuropean Journal of Immunology, 1984